Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Ensuring trial validity by data quality assurance and diversification of monitoring methods
by
Buyse, Marc
, Altman, Douglas G
, Emberson, Jonathan R
, Harrell, Frank E
, Baigent, Colin
in
Bias
/ Clinical trials
/ Clinical Trials Data Monitoring Committees - organization & administration
/ Clinical Trials Data Monitoring Committees - statistics & numerical data
/ Design of experiments
/ Errors
/ Humans
/ Quality Control
/ Randomized Controlled Trials as Topic - methods
/ Randomized Controlled Trials as Topic - statistics & numerical data
/ Research Design
/ Research methodology
/ Risk Assessment
2008
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Ensuring trial validity by data quality assurance and diversification of monitoring methods
by
Buyse, Marc
, Altman, Douglas G
, Emberson, Jonathan R
, Harrell, Frank E
, Baigent, Colin
in
Bias
/ Clinical trials
/ Clinical Trials Data Monitoring Committees - organization & administration
/ Clinical Trials Data Monitoring Committees - statistics & numerical data
/ Design of experiments
/ Errors
/ Humans
/ Quality Control
/ Randomized Controlled Trials as Topic - methods
/ Randomized Controlled Trials as Topic - statistics & numerical data
/ Research Design
/ Research methodology
/ Risk Assessment
2008
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Ensuring trial validity by data quality assurance and diversification of monitoring methods
by
Buyse, Marc
, Altman, Douglas G
, Emberson, Jonathan R
, Harrell, Frank E
, Baigent, Colin
in
Bias
/ Clinical trials
/ Clinical Trials Data Monitoring Committees - organization & administration
/ Clinical Trials Data Monitoring Committees - statistics & numerical data
/ Design of experiments
/ Errors
/ Humans
/ Quality Control
/ Randomized Controlled Trials as Topic - methods
/ Randomized Controlled Trials as Topic - statistics & numerical data
/ Research Design
/ Research methodology
/ Risk Assessment
2008
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Ensuring trial validity by data quality assurance and diversification of monitoring methods
Journal Article
Ensuring trial validity by data quality assurance and diversification of monitoring methods
2008
Request Book From Autostore
and Choose the Collection Method
Overview
Errors in the design, the conduct, the data collection process, and the analysis of a randomized trial have the potential to affect not only the safety of the patients in the trial, but also, through the introduction of bias, the safety of future patients. Trial monitoring, defined broadly to include methods of oversight which begin when the study is designed and continue until it is reported in a publication, has a role to play in eliminating such errors. On-site monitoring can be extremely inefficient for the identification of errors most likely to compromise patient safety or bias study results. However, a variety of other monitoring strategies offer alternatives to on-site monitoring. Each new trial should conduct a risk assessment to identify the optimal means of monitoring, taking into account the likely sources of error, their consequences for patients, the study's validity, and the available resources. Trial management committees should consider central statistical monitoring a key aspect of such monitoring. The systematic application of this approach would be likely to lead to tangible benefits, and resources that are currently wasted on inefficient on-site monitoring could be diverted to increasing trial sample sizes or conducting more trials. Clinical Trials 2008; 5: 49—55. http://ctj.sagepub.com
Publisher
Sage Publications,Sage Publications Ltd
This website uses cookies to ensure you get the best experience on our website.